首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
【24h】

Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.

机译:卟啉胆碱脱氨酶在肝细胞中的过度表达,而不是在红细胞中的过表达,可以防止毒性卟啉前体在急性间歇性卟啉症小鼠模型中的积累。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND & AIMS: Acute intermittent porphyria (AIP) is characterized by hepatic porphobilinogen deaminase (PBGD) deficiency resulting in a marked overproduction of presumably toxic porphyrin precursors. Our study aimed to assess the protective effects of bone marrow transplantation or PBGD gene transfer into the liver against phenotypic manifestations of acute porphyria attack induced in an AIP murine model. METHODS: Lethally irradiated AIP mice were intravenously injected with 5x10(6) nucleated bone marrow cells from wild type or AIP donor mice. To achieve liver gene transfer, AIP mice received via hydrodynamic injection plasmids expressing human PBGD or luciferase, driven by a liver-specific promoter. RESULTS: Erythrocyte PBGD activity increased 2.4-fold in AIP mice receiving bone marrow cells from normal animals. Nevertheless, phenobarbital administration in these mice reproduced key features of acute attacks, such as massively increased urinary porphyrin precursor excretion and decreased motor coordination. Hepatic PBGD activity increased 2.2-fold after hydrodynamic injection of therapeutic plasmid. Mice injected with the luciferase control plasmid showed a high excretion of porphyrin precursors after phenobarbital administration whereas just a small increase was observed in AIP mice injected with the PBGD plasmid. Furthermore, motor disturbance was almost completely abolished in AIP mice treated with the therapeutic plasmid. CONCLUSIONS: PBGD deficiency in erythroid tissue is not associated with phenotypic manifestations of acute porphyria. In contrast, PBGD over-expression in hepatocytes, albeit in a low proportion, reduced precursor accumulation, which is the hallmark of acute porphyric attacks. Liver-directed gene therapy might offer an alternative to liver transplantation applicable in patients with severe and recurrent manifestations.
机译:背景与目的:急性间歇性卟啉症(AIP)的特征是肝性卟啉胆碱原脱氨酶(PBGD)缺乏,导致明显有毒的卟啉前体产生。我们的研究旨在评估骨髓移植或PBGD基因转移入肝脏对AIP鼠模型诱发的急性卟啉症发作的表型表现的保护作用。方法:对经放射照射的AIP小鼠静脉注射来自野生型或AIP供体小鼠的5x10(6)有核骨髓细胞。为了实现肝脏基因转移,AIP小鼠通过水动力注射质粒表达,该质粒表达人PBGD或萤光素酶,由肝脏特异性启动子驱动。结果:接受正常动物骨髓细胞的AIP小鼠的红细胞PBGD活性增加了2.4倍。尽管如此,在这些小鼠中苯巴比妥给药仍具有急性发作的关键特征,例如尿卟啉前体排泄大量增加和运动协调性降低。水动力注射治疗性质粒后,肝PBGD活性增加了2.2倍。注射荧光素酶对照质粒的小鼠在苯巴比妥给药后显示出卟啉前体的高排泄,而在注射PBGD质粒的AIP小鼠中仅观察到少量增加。此外,在用治疗性质粒治疗的AIP小鼠中,运动障碍几乎被完全消除。结论:红细胞组织中PBGD缺乏与急性卟啉症的表型表现无关。相反,PBGD在肝细胞中的过表达(尽管比例较低)减少了前体积聚,这是急性卟啉症发作的标志。肝定向基因疗法可能为重度和复发性表现的患者提供替代肝移植的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号